ETHAN: A phase II study comparing different endocrine therapies for male breast cancer.
Year: 2024
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Jose Pablo Leone, Kathryn Jean Ruddy, Naim Rashid, Jasmine S. Sukumar, Sharon H. Giordano, Gaorav P. Gupta, Susan G. Hilsenbeck, Elaine M. Walsh, Igor Makhlin, Tamara Ortiz-Perez, Yara Abdou, Jessica Mezzanotte Sharpe, Priscilla F. McAuliffe, Ben Ho Park, Liza M. Quintana, Stuart J. Schnitt, Philip Merle Spanheimer, Antonio C. Wolff, Ian E. Krop, Alastair Mark Thompson
Institutions: Harvard University, Dana-Farber Cancer Institute, Mayo Clinic, University of North Carolina at Chapel Hill, The University of Texas MD Anderson Cancer Center, Dan L Duncan Comprehensive Cancer Center, Memorial Sloan Kettering Cancer Center, Georgetown University, Georgetown University Medical Center, Georgetown Lombardi Comprehensive Cancer Center, University of Pennsylvania, Baylor College of Medicine, UNC Lineberger Comprehensive Cancer Center, Vanderbilt University Medical Center, University of Pittsburgh, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Vanderbilt-Ingram Cancer Center, Beth Israel Deaconess Medical Center, Yale Cancer Center
Language: English
Topic: Male Breast Health Studies
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4399150772